Pricing Model
Supports the estimation of access-based prices for innovative health technologies by linking value, costs, and stakeholder perspectives. This card is currently a visual façade for the upcoming model flow.
Running model…
Decision support for innovative health technologies
Welcome to the ASCERTAIN Policy Support Tool
This web-based platform provides interactive models and analytical tools to support transparent, evidence-based decision-making on pricing, reimbursement, and access to innovative health technologies.
Developed within the ASCERTAIN project, the tool integrates cost-effectiveness, budget impact, and policy-relevant modelling approaches, allowing users to explore scenarios, assess uncertainty, and adapt inputs to different healthcare settings.
Choose ModelExplore ASCERTAIN Models
The ASCERTAIN models provide a set of open and adaptable analytical tools to support decision-making on innovative health technologies. They integrate different perspectives on value, costs, and access, and allow users to explore policy scenarios, assess uncertainty, and compare alternative approaches.
Each model addresses a specific aspect of pricing, reimbursement, or evaluation while remaining flexible to different healthcare system contexts.
I need help choosing a modelOur Models
CAR-T Cost-Effectiveness Model
Partitioned survival (OS/PFS), ICER & budget impact. Includes pricing corridor and uptake scenarios.
NGS Diagnostics Core Model
Decision-tree for diagnostic strategies; sensitivity/specificity and downstream costs.
Partitioned Survival Core Model
Generic PartSurv for quick scenarios; compare a new intervention vs comparator.
About ASCERTAIN
A policy support tool for more transparent access decisions
ASCERTAIN addresses the need of patients, physicians, payers, regulators, and manufacturers to improve affordability and accessibility to innovative health technologies in Europe.
The tool is designed to help decision-makers understand how much a technology should cost, the value it provides for patients, and its potential impact on the healthcare budget across different system settings.
The current release focuses on interactive modelling workflows that can be adapted to different national contexts through configurable assumptions, country profiles, and scenario exploration.
Learn moreFAQ
The tool combines web-based user journeys with health-economic models so users can
explore assumptions, compare scenarios, and document assessment decisions in a
consistent way.
The models support pricing, cost-effectiveness, diagnostics, budget impact, and
reimbursement-oriented scenario work. Each model focuses on a different decision
question while keeping the workflow adaptable to context-specific inputs.
It is intended for stakeholders involved in evidence-based pricing, reimbursement,
and access decisions, including HTA teams, payers, researchers, and policy-focused
project partners.
By improving transparency around value, affordability, and reimbursement choices, the
tool supports better-informed decisions that can ultimately improve access to
innovative health technologies.
Our Partners
Policy Support Tool
This tool has been developed as part of the ASCERTAIN project. The ASCERTAIN project has received funding from the European Union under Grant Agreement 101094938.